Medpace Holdings (MEDP) Gross Profit (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Gross Profit data on file, last reported at $201.6 million in Q2 2026.

• Quarterly Gross Profit rose 12.01% year-over-year to $201.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $800.2 million (up 13.4% YoY) and the FY2025 annual result came in at $760.6 million, up 15.89% from the prior year.
• Gross Profit grew to $201.6 million in Q2 2026, from $196.3 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $205.3 million in Q4 2025 to a low of $98.7 million in Q1 2022.
• A 5-year average of $154.0 million and a median of $154.5 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit surged 36.67% — and 2026, when it gained 10.08%.
• Tracing MEDP's Gross Profit over 5 years: stood at $115.7 million in 2022, then increased by 18.21% to $136.8 million in 2023, then surged by 30.34% to $178.3 million in 2024, then gained by 15.14% to $205.3 million in 2025, then slipped by 1.79% to $201.6 million in 2026.
• The last three Gross Profit figures came in at $201.6 million (Q2 2026), $196.3 million (Q1 2026), and $205.3 million (Q4 2025), per Business Quant data.